The trial met both endpoints in the readout, removing the inconclusive outcome management itself had flagged, and short ...

People given the experimental vaccine with standard treatment lived longer without their cancer returning, the companies ...

Moderna's melanoma vaccine is generating buzz after a Phase 3 breakthrough. But can it actually cure skin cancer? What ...

CBS News medical correspondent Dr. Céline Gounder, who has had melanoma herself, said Moderna's experimental trial is "a big ...

A personalized mRNA vaccine for melanoma reduced the risk of the cancer returning in a phase III clinical trial, the ...

The companies have not published the trial data but said in a news release that the experimental treatment extended the time ...

Moderna and Merck said their personalized cancer treatment showed positive results in their first-ever late-stage trial. Here ...

A personalized mRNA cancer vaccine combined with the immunotherapy Keytruda succeeded in a late-stage trial for the deadly ...

Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of ...

Merck and Moderna say their personalized cancer vaccine reduced melanoma recurrence and spread in a Phase 3 trial.

Moderna, Inc. (NASDAQ:MRNA) has delivered a major boost to its turnaround story. Its personalized mRNA cancer vaccine, Intismeran, met the main goal of reducing melanoma recurrence and also showed a ...